Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
Submitted by
admin
on February 14, 2012 - 11:18am
Source:
Fierce Biotech
News Tags:
Stromedix
Biogen Idec
M&A
STX-100
fibrosis
Headline:
Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
Do Not Allow Advertisers to Use My Personal information
